Detalhe da pesquisa
1.
Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced Immunogenicity.
J Proteome Res
; 19(9): 3792-3806, 2020 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32786679
2.
Correction to "Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced Immunogenicity".
J Proteome Res
; 20(1): 1103, 2021 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33025787
3.
First-in-Man Study With Inclacumab, a Human Monoclonal Antibody Against P-selectin.
J Cardiovasc Pharmacol
; 65(6): 611-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25714598
4.
Antibody-based proteomics and biomarker research - current status and limitations.
Proteomics
; 14(6): 774-83, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24520068
5.
Managing the Impact of Immunogenicity in an Era of Immunotherapy: From Bench to Bedside.
J Pharm Sci
; 110(7): 2575-2584, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33812888
6.
Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.
Sci Transl Med
; 7(316): 316ra193, 2015 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26631632
7.
HLA-G, pre-eclampsia, immunity and vascular events.
J Reprod Immunol
; 59(2): 219-34, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12896824
8.
Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4.
Clin Kidney J
; 7(2): 167-173, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24683472
9.
Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast.
Eur J Immunol
; 32(12): 3576-86, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12516543